Cargando…

New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma

Cholangiocarcinoma (CCA) represents a disease entity that comprises a heterogeneous group of biliary malignant neoplasms, with variable clinical presentation and severity. It may be classified according to its anatomical location and distinguished in intrahepatic (iCCA), perihilar (pCCA), or distal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Massironi, Sara, Pilla, Lorenzo, Elvevi, Alessandra, Longarini, Raffaella, Rossi, Roberta Elisa, Bidoli, Paolo, Invernizzi, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140695/ https://www.ncbi.nlm.nih.gov/pubmed/32168869 http://dx.doi.org/10.3390/cells9030688

Ejemplares similares

Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review
por: Elvevi, Alessandra, et al.
Publicado: (2023)

Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options
por: Rossi, Roberta Elisa, et al.
Publicado: (2023)

Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are
por: Rossi, Roberta Elisa, et al.
Publicado: (2022)

Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies
por: Rossi, Roberta Elisa, et al.
Publicado: (2021)

Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis
por: Massironi, Sara, et al.
Publicado: (2023)

Interaction between Gut Microbiota and Celiac Disease: From Pathogenesis to Treatment
por: Rossi, Roberta Elisa, et al.
Publicado: (2023)

Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms
por: Massironi, Sara, et al.
Publicado: (2023)

Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance
por: Gallo, Camilla, et al.
Publicado: (2022)

Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review
por: Elvevi, Alessandra, et al.
Publicado: (2022)

Therapeutic Challenges for Gastric Neuroendocrine Neoplasms: Take It or Leave It?
por: Cavalcoli, Federica, et al.
Publicado: (2023)

Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success
por: Cazzaniga, Marina Elena, et al.
Publicado: (2019)

Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma
por: Najran, Pavan, et al.
Publicado: (2017)

Emerging Therapies for Advanced Cholangiocarcinoma: An Updated Literature Review
por: Vignone, Anthony, et al.
Publicado: (2021)

Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells
por: Raggi, Chiara, et al.
Publicado: (2017)

Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer
por: Stanzione, Brigida, et al.
Publicado: (2023)

Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options
por: Diwakarla, Chandra, et al.
Publicado: (2017)

Emerging Therapeutic Options for the Management of COPD
por: Reid, Debra J., et al.
Publicado: (2013)

Emerging Therapeutic Options for Chronic Pruritus
por: Reszke, Radomir, et al.
Publicado: (2020)

Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives
por: Pastore, Mirella, et al.
Publicado: (2020)

Advances in therapeutic options for portal hypertension
por: Vilaseca, Marina, et al.
Publicado: (2018)

Novel Pharmacological Options in the Treatment of Cholangiocarcinoma: Mechanisms of Resistance
por: Marin, Jose J. G., et al.
Publicado: (2021)

The Increasing Incidence of Neuroendocrine Neoplasms Worldwide: Current Knowledge and Open Issues
por: Rossi, Roberta Elisa, et al.
Publicado: (2022)

Recent Advances in Understanding Cholangiocarcinoma
por: Kennedy, Lindsey, et al.
Publicado: (2017)

Recent Advances and Therapeutic Options in Lambert-Eaton Myasthenic Syndrome
por: Anwar, Arsalan, et al.
Publicado: (2019)

Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges
por: Yang, Yang, et al.
Publicado: (2020)

Phytotherapy: emerging therapeutic option in urologic disease
por: Kim, Sae Woong
Publicado: (2012)

Leprosy stigma & the relevance of emergent therapeutic options
por: Sardana, Kabir, et al.
Publicado: (2020)

Emerging therapeutic options in inflammatory bowel disease
por: Yamamoto-Furusho, Jesus K, et al.
Publicado: (2021)

The Emergence of Mpox: Epidemiology and Current Therapeutic Options
por: Ranjan, Samriddhi, et al.
Publicado: (2023)

Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future Prospects
por: Pilla, Lorenzo, et al.
Publicado: (2020)

New Therapeutic Options for Advanced Hepatocellular Carcinoma
por: Ma, Yu-Shui, et al.
Publicado: (2020)

Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers
por: Tortora, Fabiana, et al.
Publicado: (2023)

Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma
por: Azizi, Alexander A., et al.
Publicado: (2020)

New Options for Systemic Therapies in Intrahepatic Cholangiocarcinoma (iCCA)
por: Becht, Rafał, et al.
Publicado: (2023)

DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma
por: Lorenzo, Nevi, et al.
Publicado: (2021)

Advances in the management of cholangiocarcinoma
por: Zori, Andreas G, et al.
Publicado: (2021)

Current and Emerging Therapeutic Options in Adrenocortical Cancer Treatment
por: Stigliano, Antonio, et al.
Publicado: (2012)

Emerging therapeutic options for sporadic inclusion body myositis
por: Alfano, Lindsay N, et al.
Publicado: (2015)

Molecular Targets and Emerging Therapeutic Options for Uterine Leiomyosarcoma
por: Miller, Heather, et al.
Publicado: (2016)

An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
por: Davis, Alexander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vit5oajpcrjcgbnhot96npavtk